The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
We recently compiled a list of the Top 10 Must-See AI News Updates for Investors. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback